THE ROLE OF GENDER CHARACTERISTICS OF PATIENTS IN THE SPREAD OF COVID-19 DISEASE IN THE BUKHARA REGION.

Authors

  • Omonov Olimjon Yunusovich Author

Keywords:

COVID-19, gender characteristics, gender groups

Abstract

This article examines the role of gender characteristics of patients in the spread of COVID-19 disease. The study analyzed data on a higher incidence of COVID-19 in representatives of one gender or another.

References

1. WHO. Weekly epidemiological update on COVID-19 — 25 May 2021. URL: https://www.who.int/publications/m/item/ weekly-epidemiological-update-on-covid-19---25-may-2021.

2. Iba T., Connors J.M., Levy J.H. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res 2020

69(12): 1181–1189, https://doi.org/10.1007/s00011-020-01401-6.

3. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., Zhao Y., Li Y., Wang X., Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020

323(11): 1061–1069, https://doi. org/10.1001/jama.2020.1585.

4. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020

323(13): 1239–1242, https://doi.org/10.1001/ jama.2020.2648.

5. Tsatsakis A., Calina D., Falzone L., Petrakis D., Mitrut R., Siokas V., Pennisi M., Lanza G., Libra M., Doukas S.G., Doukas P.G., Kavali L., Bukhari A., Gadiparthi C., Vageli D.P., Kofteridis D.P., Spandidos D.A., Paoliello M.M.B., Aschner M., Docea A.O. SARS-CoV-2 pathophysiology and its clinical implications: an integrative overview of the pharmacotherapeutic management of COVID-19. Food Chem Toxicol 2020

146: 111769, https://doi.org/10.1016/j. fct.2020.111769.

6. Pagliaro P. Is macrophages heterogeneity important in determining COVID-19 lethality? Med Hypotheses 2020

143: 110073, https://doi.org/10.1016/j.mehy.2020.110073.

7. Sze S., Pan D., Nevill C.R., Gray L.J., Martin C.A., Nazareth J., Minhas J.S., Divall P., Khunti K., Abrams K.R., Nellums L.B., Pareek M. Ethnicity and clinical outcomes in COVID-19: a systematic review and meta-analysis. EClinicalMedicine 2020

29: 100630, https://doi.org/10.1016/j. eclinm.2020.100630.

8. Zhang J., Wang X., Jia X., Li J., Hu K., Chen G., Wei J., Gong Z., Zhou C., Yu H., Yu M., Lei H., Cheng F., Zhang B., Xu Y., Wang G., Dong W. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect 2020

26(6): 767–772, https://doi. org/10.1016/j.cmi.2020.04.012.

9. Liu Y., Mao B., Liang S., Yang J.W., Lu H.W., Chai Y.H., Wang L., Zhang L., Li Q.H., Zhao L., He Y., Gu X.L., Ji X.B., Li L., Jie Z.J., Li Q., Li X.Y., Lu H.Z., Zhang W.H., Song Y.L., Qu J.M., Xu J.F.

Shanghai Clinical Treatment Experts Group for COVID-19. Association between age and clinical characteristics and outcomes of COVID-19. Eur Respir J 2020

55(5): 2001112, https://doi.org/10.1183/13993003.01112-2020.

10. Liu X., Lv J., Gan L., Zhang Y., Sun F., Meng B., Jheon A., Yan F., Li B., Xuan Z., Ma X., Wulasihana M. Comparative analysis of clinical characteristics, imaging and laboratory findings of different age groups with COVID-19. Indian J Med Microbiol 2020

38(1): 87–93, https://doi. org/10.4103/ijmm.ijmm_20_133. 11. Liu K., Chen Y., Lin R., Han K. Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Infect 2020

80(6): e14–e18, https:// doi.org/10.1016/j.jinf.2020.03.005.

12. Moreno Fernández-Ayala D.J., Navas P., López-Lluch G. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease. Exp Gerontol 2020

142: 111147, https:// doi.org/10.1016/j.exger.2020.111147.

13. McGuire P.J. Mitochondrial dysfunction and the aging immune system. Biology (Basel) 2019

8(2): 26, https://doi. org/10.3390/biology8020026.

14. López-Lluch G. Mitochondrial activity and dynamics changes regarding metabolism in ageing and obesity. Mech Ageing Dev 2017

162: 108–121, https://doi.org/10.1016/j. mad.2016.12.005.

15. Meng Y., Wu P., Lu W., Liu K., Ma K., Huang L., Cai J., Zhang H., Qin Y., Sun H., Ding W., Gui L., Wu P. Sexspecific clinical characteristics and prognosis of Coronavirus Disease-19 infection in Wuhan, China: a retrospective study of 168 severe patients. PLoS Pathog 2020

16(4): e1008520, https://doi.org/10.1371/journal.ppat.1008520.

16. Wenham C, Smith J, Morgan R. COVID-19: the gendered impacts of the outbreak. Lancet. (2020) 395:846–8. doi: 10.1016/S0140-6736(20)30526-2

17. World Health Organization. Taking Sex and Gender into Account in Emerging Infectious Disease Programme : An Analytical Framework. (2011). Available online at: https://apps.who.int/iris/bitstream/handle/10665/207693/9789290615323_eng. pdf (accessed July 23, 2022).

18. Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. (2020) 19:1–13. doi: 10.1186/s13293-020-00304-9

4. Scully EP, Haverfield J, Ursin RL, Tannenbaum C, Klein SL. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. (2020) 20:442–7. doi: 10.1038/s41577-020-0348-8

20. Kabeer N, Razavi S, van der Meulen Rodgers Y. Feminist economic perspectives on the COVID-19 pandemic. Fem Econ. (2021) 27:1–29. doi: 10.1080/13545701.2021.187690

Published

2026-08-16